Evidence map›Paper›PMID 31653078›Full record

ReviewInternational journal of molecular sciences2019

The Role of the Gut Microbiota in Colorectal Cancer Causation.

Eiman A Alhinai, Gemma E Walton, Daniel M Commane

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Analysis of Microbiome for AP and CRC Discrimination.Bioengineering (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.Cellular and molecular gastroenterology and hepatology · 2025
    Review
  16. From gut to proteomics: the impact ofFrontiers in oncology · 2025
    Article
  17. Colorectal Cancer: Risk Factors, Novel Approaches in Molecular Screening and Treatment.International journal of molecular and cellular medicine · 2025
    Review
  18. Review
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Eiman A AlhinaiDietetics Department, Al Nahdha Hospital, Ministry of Health, Muscat, PO Box 937, Ruwi, Muscat PC 112, Oman. Alhinaie78@gmail.com.
Gemma E WaltonDepartment of Food and Nutritional Sciences, University of Reading, Reading RG6 6UA, UK. g.e.walton@reading.ac.uk.
Daniel M CommaneDepartment of Applied and Health Sciences, University of Northumbria, Newcastle Upon Tyne NE1 8ST, UK. Daniel.commane@northumbria.ac.uk.ORCID 0000-0002-0154-8540
Al Nahdha Hospital · OMNorthumbria University · GBUniversity of Reading · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we reviewed emerging evidence on the role of the microbial community in colorectal carcinogenesis. A healthy gut microbiota promotes intestinal homeostasis and can exert anti-cancer effects; however, this microbiota also produces a variety of metabolites that are genotoxic and which can negatively influence epithelial cell behaviour. Disturbances in the normal microbial balance, known as dysbiosis, are frequently observed in colorectal cancer (CRC) patients. Microbial species linked to CRC include certain strains of

Indexed as

Gastrointestinal MicrobiomeAnimalsBacteroidesColorectal NeoplasmsDNA DamageFusobacteriumHumansInflammationStreptococcusTumor MicroenvironmentBacteroidescolorectal cancerEscherichia coliFusobacteriagenotoxicitygutmicrobiotaStreptococcus Gallolyticus

Identifiers

PMID31653078
PMCPMC6862640
OpenAlexW2981557809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.